| Neck Carcinoma altered in cohorts of …ALTERED_INderived184 of 184show fewer |
|---|
| ← altered in cohorts of | BRAF 302 / 507 cases (60 %) · ssm · TCGA-THCA · largest of 5 cohorts | — | — | Thyroid Gland Carcinoma | 5 | Observed | gdc | graph → |
| ← altered in cohorts of | OR11H12 104 / 394 cases (26 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM243B 99 / 394 cases (25 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNE1B 99 / 394 cases (25 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SMIM11B 99 / 394 cases (25 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SMIM34B 99 / 394 cases (25 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OR11H1 98 / 394 cases (25 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POTEH 96 / 394 cases (24 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CNTNAP3C 89 / 394 cases (23 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPATA31A7 89 / 394 cases (23 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPATA31A5 88 / 394 cases (22 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FOXD4L5 87 / 394 cases (22 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ANKRD20A4P 85 / 394 cases (22 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CBWD5 84 / 394 cases (21 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FOXD4L4 84 / 394 cases (21 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POTEM 84 / 394 cases (21 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ANKRD20A3P 79 / 394 cases (20 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF658 77 / 394 cases (20 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPATA31A3 76 / 394 cases (19 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POTEG 70 / 394 cases (18 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TPTE 68 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ANKRD20A1 67 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CBWD3 67 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM86B2 67 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LINC02203 67 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POTEB 67 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POTEB3 67 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OR4F4 66 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OR4M2 66 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OR4N4 66 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FOXD4L3 65 / 394 cases (16 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPATA31A6 62 / 394 cases (16 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB130A 60 / 394 cases (15 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POTEB2 60 / 394 cases (15 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RRP7A 59 / 394 cases (15 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SHANK3 58 / 394 cases (15 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | WASHC1 58 / 394 cases (15 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CNTNAP3B 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB105B 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB106B 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB107B 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM90A10P 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM90A17P 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM90A19P 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM90A8P 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM90A9P 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TCN2 71 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | THOC5 71 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ADM2 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ALG12 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ARSA 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCDC117 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CHKB 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CHKB-CPT1B 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CRELD2 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB103B 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB104A 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB104B 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB105A 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB106A 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB107A 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB4B 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM90A16P 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM90A18P 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM90A22P 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM90A23P 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM90A7P 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IL17REL 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KLHDC7B 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LMF2 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MAPK11 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MAPK12 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MIOX 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MLC1 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ODF3B 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PIM3 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLXNB2 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PPP6R2 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PRR23D1 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SCO2 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SELENOO 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPAG11A 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPAG11B 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SYCE3 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TRABD 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TUBGCP6 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TYMP 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZBED4 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CELSR1 70 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEPDC5 70 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EIF4ENIF1 70 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PISD 70 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLA2G3 70 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RFPL1 70 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SEC14L2 70 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SEC14L4 70 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SF3A1 70 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SFI1 70 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TNRC6B 70 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNRF3 70 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | AP1B1 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ASCC2 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | C22orf42 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CABP7 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CASTOR1 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCDC157 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CHEK2 69 / 507 cases (14 %) · ssm · TCGA-THCA · largest of 2 cohorts | — | — | Thyroid Gland Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | DENND6B 69 / 507 cases (14 %) · ssm · TCGA-THCA · largest of 2 cohorts | — | — | Thyroid Gland Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | DRG1 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DUSP18 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ELFN2 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EMID1 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EWSR1 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FBXO7 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GAL3ST1 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GAS2L1 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HORMAD2 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | INPP5J 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KREMEN1 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LIF 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LIMK2 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MORC2 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MPPED1 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MTFP1 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MTMR3 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NEFH 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NF2 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NIPSNAP1 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OSBP2 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OSM 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PATZ1 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PES1 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PIK3IP1 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PRR14L 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RASL10A 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RHBDD3 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RNF185 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RNF215 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SEC14L3 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SEC14L6 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SELENOM 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC35E4 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC5A1 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SMTN 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TBC1D10A 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TUG1 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | UQCR10 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | YWHAH 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZMAT5 69 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ACR 68 / 507 cases (13 %) · ssm · TCGA-THCA · largest of 2 cohorts | — | — | Thyroid Gland Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | ANKRD54 68 / 507 cases (13 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | APOBEC3C 68 / 507 cases (13 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | APOL2 68 / 507 cases (13 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | APOL5 68 / 507 cases (13 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BPIFC 68 / 507 cases (13 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | C22orf31 68 / 507 cases (13 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CARD10 68 / 507 cases (13 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CBX6 68 / 507 cases (13 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CSF2RB 68 / 507 cases (13 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DMC1 68 / 507 cases (13 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EIF3D 68 / 507 cases (13 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EIF3L 68 / 507 cases (13 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM83F 68 / 507 cases (13 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FBLN1 68 / 507 cases (13 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HSCB 68 / 507 cases (13 %) · ssm · TCGA-THCA · largest of 2 cohorts | — | — | Thyroid Gland Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | LARGE1 68 / 507 cases (13 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MAPK8IP2 68 / 507 cases (13 %) · ssm · TCGA-THCA · largest of 2 cohorts | — | — | Thyroid Gland Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | MEI1 68 / 507 cases (13 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MRTFA 68 / 507 cases (13 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NCAPH2 68 / 507 cases (13 %) · ssm · TCGA-THCA · largest of 2 cohorts | — | — | Thyroid Gland Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | PKDREJ 68 / 507 cases (13 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PPARA 68 / 507 cases (13 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PRR5-ARHGAP8 68 / 507 cases (13 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RABL2B 68 / 507 cases (13 %) · ssm · TCGA-THCA · largest of 2 cohorts | — | — | Thyroid Gland Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | RTCB 68 / 507 cases (13 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SBF1 68 / 507 cases (13 %) · ssm · TCGA-THCA · largest of 2 cohorts | — | — | Thyroid Gland Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | SEZ6L 68 / 507 cases (13 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SGSM3 68 / 507 cases (13 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SYN3 68 / 507 cases (13 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TIMP3 68 / 507 cases (13 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TRIOBP 68 / 507 cases (13 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | WNT7B 68 / 507 cases (13 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NRAS 39 / 496 cases (7.9 %) · ssm · thpa_tcga_gdc · largest of 4 cohorts | — | — | Thyroid Gland Papillary Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TERT 37 / 496 cases (7.5 %) · ssm · thca_tcga_pub | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | cbioportal | graph → |